Compare MLYS & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MLYS | KTB |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Apparel |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.6B |
| IPO Year | 2023 | N/A |
| Metric | MLYS | KTB |
|---|---|---|
| Price | $37.07 | $62.86 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | $47.33 | ★ $96.38 |
| AVG Volume (30 Days) | ★ 1.5M | 751.2K |
| Earning Date | 02-11-2026 | 11-03-2025 |
| Dividend Yield | N/A | ★ 3.37% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.88 |
| Revenue | N/A | ★ $2,833,659,000.00 |
| Revenue This Year | N/A | $20.46 |
| Revenue Next Year | N/A | $10.92 |
| P/E Ratio | ★ N/A | $16.21 |
| Revenue Growth | N/A | ★ 9.91 |
| 52 Week Low | $8.24 | $50.00 |
| 52 Week High | $47.65 | $96.80 |
| Indicator | MLYS | KTB |
|---|---|---|
| Relative Strength Index (RSI) | 43.16 | 31.72 |
| Support Level | $36.50 | $61.71 |
| Resistance Level | $38.23 | $64.55 |
| Average True Range (ATR) | 1.68 | 2.34 |
| MACD | 0.09 | -0.41 |
| Stochastic Oscillator | 41.96 | 9.26 |
Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.
Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.